Sutro Biopharma (STRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements ...

Microsoft (MSFT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead ...

Modiv Industrial, Inc. (MDV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at $1.73 per share, indicating 380.6% ...

Axon Enterprise is one of 213 individual stocks in the Industrial Products sector. Collectively, these companies sit at #14 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different ...

The Zacks Rank is a unique, proprietary stock-rating model that utilizes earnings estimate revisions to help investors build a winning portfolio. There are four main factors behind the Zacks Rank ...

A unique, proprietary stock-rating model, the Zacks Rank uses earnings estimate revisions, or changes to a company's earnings expectations, to help investors create a winning portfolio.